Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats

Sorafenib has been used as a standard therapy for advanced hepatocellular carcinoma (HCC). In Asia, patients with HCC are potentially treated with the combination of sorafenib and Chinese herbal medicines to improve the efficiency and reduce the side effects of sorafenib. However, limited informatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, Chin-Tsung, Cheng, Yung-Yi, Tsai, Tung-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152211/
https://www.ncbi.nlm.nih.gov/pubmed/28640225
http://dx.doi.org/10.3390/molecules22071034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152211/
https://www.ncbi.nlm.nih.gov/pubmed/28640225
http://dx.doi.org/10.3390/molecules22071034

Ejemplares similares